ResearcherMayo ClinicNo recent work listed
Liewei Wang
Matched on ORCID iD 0000-0003-3818-8531; OpenAlex author ID A5069578729; NIH RePORTER profile ID 8822085. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 3)
- Trials
- 0
- Grants
- 1
- Labs led
- 1
- Collaborators
- 25
2012: 2 papers · 2013: 1 paper, 1 grant · 2014: 1 paper · 2015: none · 2016: 2 papers
Papers 6
- Genetic variations associated with gemcitabine treatment outcome in pancreatic cancer. Last author DOI 10.1097/fpc.0000000000000241↗
- HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy. Co-author DOI 10.1158/0008-5472.can-15-0671↗
- Snail contributes to the maintenance of stem cell-like phenotype cells in human pancreatic cancer. Last author DOI 10.1371/journal.pone.0087409↗
- Contribution of FKBP5 genetic variation to gemcitabine treatment and survival in pancreatic adenocarcinoma. Last author DOI 10.1371/journal.pone.0070216↗
- A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303. Co-author DOI 10.1158/1078-0432.ccr-11-1387↗
- FKBP5 as a selection biomarker for gemcitabine and Akt inhibitors in treatment of pancreatic cancer. First author DOI 10.1371/journal.pone.0036252↗
Grants 1
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Liang Li · 3 shared papers, 2012–2016 · strength 0.11
- Paper Genetic variations associated with gemcitabine treatment outcome in pancreatic cancer. DOI 10.1097/fpc.0000000000000241↗
- Paper Contribution of FKBP5 genetic variation to gemcitabine treatment and survival in pancreatic adenocarcinoma. DOI 10.1371/journal.pone.0070216↗
- Paper A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 803… DOI 10.1158/1078-0432.ccr-11-1387↗
- Brooke L. Fridley · 2 shared papers, 2013–2016 · strength 0.09
- Gloria M. Petersen · 2 shared papers, 2013–2016 · strength 0.09
- Junmei Hou · 1 shared paper, 2012 · strength 0.06
- Jianwei Zhang · 1 shared paper, 2016 · strength 0.06
- Robert R. McWilliams · 1 shared paper, 2016 · strength 0.06
- Zhenkun Lou · 1 shared paper, 2016 · strength 0.05
- Wenhui Lou · 1 shared paper, 2016 · strength 0.05
- Yuan Fang · 1 shared paper, 2016 · strength 0.05
- Tongzheng Liu · 1 shared paper, 2016 · strength 0.05
- Min Deng · 1 shared paper, 2016 · strength 0.05
- Fang Xie · 1 shared paper, 2016 · strength 0.05
- Wei Zhou · 1 shared paper, 2014 · strength 0.04
- Yunyun Xu · 1 shared paper, 2014 · strength 0.04
- Yiping Mou · 1 shared paper, 2014 · strength 0.04
- Katarzyna A. Ellsworth · 1 shared paper, 2013 · strength 0.03
- Federico Innocenti · 1 shared paper, 2012 · strength 0.02
- Mark J. Ratain · 1 shared paper, 2012 · strength 0.02
- Kouros Owzar · 1 shared paper, 2012 · strength 0.02
- Richard M. Goldberg · 1 shared paper, 2012 · strength 0.02
- Herbert I. Hurwitz · 1 shared paper, 2012 · strength 0.02
- Chen Jiang · 1 shared paper, 2012 · strength 0.02
- Yusuke Nakamura · 1 shared paper, 2012 · strength 0.02
- Hedy Lee Kindler · 1 shared paper, 2012 · strength 0.02
- Hitoshi Zembutsu · 1 shared paper, 2012 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.